Intralymphatic immunotherapy

The World Allergy Organization Journal
Gabriela Senti, Thomas M Kündig

Abstract

Gold Standard allergen-specific immunotherapy is associated with low efficacy because it requires either many subcutaneous injections of allergen or even more numerous sublingual allergen administrations to achieve amelioration of symptoms. Intralymphatic vaccination can maximize immunogenicity and hence efficacy. We and others have demonstrated that as few as three low dose intralymphatic allergen administrations are sufficient to effectively alleviate symptoms. Results of recent prospective and controlled trials suggest that this strategy may be an effective form of allergen immunotherapy.

References

Apr 1, 1977·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G J Juillard, P J Boyer
Mar 1, 1976·International Journal of Radiation Oncology, Biology, Physics·G J JuillardH D Snow
Oct 1, 1992·The Journal of Allergy and Clinical Immunology·G E Stewart, R F Lockey
Nov 1, 1990·The Journal of Allergy and Clinical Immunology·R F LockeyS C Bukantz
Apr 1, 1987·The Journal of Allergy and Clinical Immunology·R F LockeyS C Bukantz
Feb 1, 1996·The Journal of Allergy and Clinical Immunology·D B GoldenL M Lichtenstein
Nov 5, 1998·The Journal of Allergy and Clinical Immunology·J BousquetH J Malling
Aug 12, 1999·The New England Journal of Medicine·S R DurhamK T Nouri-Aria
Mar 17, 2000·Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology·L K Pierson-MullanyA Rosenberg
Jul 27, 2000·Seminars in Immunology·R M Zinkernagel
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·K J MaloyT M Kündig
Oct 9, 2001·The Journal of Allergy and Clinical Immunology·R F Lockey
Oct 10, 2001·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·G B PajnoS Parmiani
Apr 12, 2003·Cancer Immunology, Immunotherapy : CII·Thierry LesimpleLouis Toujas
Jan 1, 1957·International Archives of Allergy and Applied Immunology·J R FREY, P WENK
Dec 6, 2003·Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology·M L BurrUNKNOWN ISAAC Phase One Study Group
Jun 23, 2004·The Journal of Allergy and Clinical Immunology·Philip S Norman
Jun 23, 2004·The Journal of Allergy and Clinical Immunology·Stephen J TillStephen R Durham
Jun 23, 2004·The Journal of Allergy and Clinical Immunology·Joost L M VissersAntoon J M van Oosterhout
Feb 1, 2005·European Journal of Immunology·P JohansenT M Kündig
May 24, 2005·European Journal of Immunology·Barbara R von BeustThomas M Kündig
Nov 1, 2005·Nature Biotechnology·I Jolanda M de VriesCarl G Figdor
Oct 6, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Amelia GroverPatrick Hwu
Dec 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thierry LesimpleVéronique Quillien
Jul 20, 2007·Biochemical Society Transactions·C RhynerR Crameri
Apr 5, 2008·European Journal of Immunology·Vania ManolovaMartin F Bachmann
Nov 13, 2008·Proceedings of the National Academy of Sciences of the United States of America·Gabriela SentiThomas M Kündig

❮ Previous
Next ❯

Citations

Jan 7, 2016·Expert Opinion on Emerging Drugs·Amelia LicariGiorgio Ciprandi
Mar 5, 2016·Current Allergy and Asthma Reports·Robbie D Pesek, Stacie M Jones
Feb 20, 2016·Biomaterials Science·Liu YangJiaoyan Ren
Mar 2, 2016·Current Opinion in Otolaryngology & Head and Neck Surgery·William R Reisacher, Theresa Schwanke
Nov 8, 2016·The Journal of Allergy and Clinical Immunology·Robert K Bush
Dec 13, 2016·Expert Review of Clinical Pharmacology·Maria IordanidouEmmanouil Paraskakis
Jul 14, 2017·Expert Review of Vaccines·Carlo IavaroneJeffrey B Ulmer
Oct 30, 2018·Allergy·Oliver PfaarLuo Zhang
Dec 1, 2017·Current Opinion in Organ Transplantation·Natalie A O'NeillJonathan S Bromberg
Feb 14, 2020·Clinical & Experimental Metastasis·Babak BananBarbara Fingleton
Jul 6, 2016·Pharmaceutical Research·Sharan Bobbala, Sarah Hook
Jan 31, 2017·Veterinary Dermatology·Douglas J DeBoer
Feb 16, 2017·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·P Zieglmayer
Aug 3, 2017·Asia Pacific Allergy·Seon Tae KimSang Pyo Lee
Jul 28, 2019·Journal of Translational Medicine·Patrick Tjok JoeJoeri L Aerts
Jun 27, 2019·Clinical Reviews in Allergy & Immunology·Abida ZahirovićMojca Lunder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
Luo ZhangDe-min Han
JAMA : the Journal of the American Medical Association
Franco FratiGiovanni Passalacqua
JAMA : the Journal of the American Medical Association
Heleen MoedPatrick Bindels
MMW Fortschritte der Medizin
Peter Stiefelhagen
International Archives of Allergy and Immunology
J M Martínez-GómezThomas M Kündig
© 2021 Meta ULC. All rights reserved